We are live on ! Find out more
GYRO icon

Gyrodyne

11 hedge funds and large institutions have $7.22M invested in Gyrodyne in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

337% more capital inflows, than outflows

Capital inflows: $3.01M | Capital outflows: $690K

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

16.77% more ownership

Funds ownership: 39.36% → 56.13% (+17%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
2
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GYRO Hedge Fund Activity: Q1 2024 in Review

11 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Gyrodyne (GYRO) for Q1 2024, worth a combined $7.22M — up 8.6% from $6.64M a quarter earlier.

Fund positioning in GYRO was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 3 trimmed.

The largest buyer was TowerView LLC, adding an estimated $1.65M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $349K.

  • 11 institutional investors held Gyrodyne (GYRO) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $7.22M of Gyrodyne stock for Q1 2024, up 8.6% quarter-over-quarter.
  • 2 funds opened new Gyrodyne positions in Q1 2024 and 2 closed out, a net change of 0 holders.
  • The largest Gyrodyne buyer in Q1 2024 was TowerView LLC, an estimated $1.65M added.
  • The largest Gyrodyne seller in Q1 2024 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $349K sold.

Based on aggregated 13F filings for Q1 2024.